These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10777377)

  • 1. Secretin treatment for autism.
    Rimland B
    N Engl J Med; 2000 Apr; 342(16):1216-7; author reply 1218. PubMed ID: 10777377
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.
    Sandler AD; Sutton KA; DeWeese J; Girardi MA; Sheppard V; Bodfish JW
    N Engl J Med; 1999 Dec; 341(24):1801-6. PubMed ID: 10588965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from secretin.
    Volkmar FR
    N Engl J Med; 1999 Dec; 341(24):1842-4. PubMed ID: 10588973
    [No Abstract]   [Full Text] [Related]  

  • 4. Secretin treatment for autism.
    Herlihy WC
    N Engl J Med; 2000 Apr; 342(16):1217; author reply 1218. PubMed ID: 10777378
    [No Abstract]   [Full Text] [Related]  

  • 5. Secretin treatment for autism.
    Said SI; Bodanszky M
    N Engl J Med; 2000 Apr; 342(16):1217-8. PubMed ID: 10777379
    [No Abstract]   [Full Text] [Related]  

  • 6. Secretin treatment for autism.
    Horvath K
    N Engl J Med; 2000 Apr; 342(16):1216; author reply 1218. PubMed ID: 10777376
    [No Abstract]   [Full Text] [Related]  

  • 7. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
    Sturmey P
    Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical treatment of pervasive developmental disorders].
    Fuentes J; Gallano I
    Rev Neurol; 2001 Aug 1-15; 33(3):208-10. PubMed ID: 11588711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of porcine secretin in children with autism and pervasive developmental disorder.
    Kern JK; Van Miller S; Evans PA; Trivedi MH
    J Autism Dev Disord; 2002 Jun; 32(3):153-60. PubMed ID: 12108616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autism: a new treatment seems unsuccessful.
    Child Health Alert; 2004 Feb; 22():1-2. PubMed ID: 15029860
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.
    Coniglio SJ; Lewis JD; Lang C; Burns TG; Subhani-Siddique R; Weintraub A; Schub H; Holden EW
    J Pediatr; 2001 May; 138(5):649-55. PubMed ID: 11343038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of transdermal secretin on behavior of children with autism.
    Ratliff-Schaub K; Carey T; Reeves GD; Rogers MA
    Autism; 2005 Jul; 9(3):256-65. PubMed ID: 15937041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of secretin in the treatment of childhood autism.
    Kamińska B; Czaja M; Kozielska E; Mazur E; Korzon M
    Med Sci Monit; 2002 Jan; 8(1):RA22-6. PubMed ID: 11782669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is secretin effective in treatment for autism spectrum disorders (ASD)?
    Jayachandra S
    Int J Psychiatry Med; 2005; 35(1):99-101. PubMed ID: 15977948
    [No Abstract]   [Full Text] [Related]  

  • 19. Administration of secretin for autism alters dopamine metabolism in the central nervous system.
    Toda Y; Mori K; Hashimoto T; Miyazaki M; Nozaki S; Watanabe Y; Kuroda Y; Kagami S
    Brain Dev; 2006 Mar; 28(2):99-103. PubMed ID: 16168596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development. Desperate parents spark search for new treatment.
    Stokstad E
    Science; 2001 Oct; 294(5540):37. PubMed ID: 11588235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.